Interactions of (-)-ilimaquinone with methylation enzymes: implications for vesicular-mediated secretion.
BACKGROUND
The marine sponge metabolite (-)-ilimaquinone has antimicrobial, anti-HIV, anti-inflammatory and antimitotic activities, inhibits the cytotoxicity of ricin and diptheria toxin, and selectively fragments the Golgi apparatus. The range of activities demonstrated by this natural product provides a unique opportunity for studying these cellular processes.


RESULTS
Affinity chromatography experiments show that (-)-ilimaquinone interacts with enzymes of the activated methyl cycle: S-adenosylmethionine synthetase, S-adenosylhomocysteinase and methyl transferases. Known inhibitors of these enzymes were found to block vesicle-mediated secretion in a manner similar to (-)-ilimaquinone. Moreover, the antisecretory effects of (-)-ilimaquinone and inhibitors of methylation chemistry, but not brefeldin A, could be reversed in the presence of the cellular methylating agent S-adenosylmethionine. Of the enzymes examined in the activated methyl cycle, S-adenosylhomocysteinase was specifically inhibited by (-)-ilimaquinone. Consistent with these observations, (-)-ilimaquinone was shown to obstruct new methylation events in adrenocorticotrophic hormone (ACTH)-secreting pituitary cells.


CONCLUSIONS
(-)-ilimaquinone inhibits cellular methylations through its interactions with S-adenosylhomocysteinase. Furthermore, these studies indicate that the inhibition of secretion by ilimaquinone is the result of the natural product's antimethylation activity. It is likely that the ability to fragment the Golgi apparatus, as well as other activities, are also related to ilimaquinone's influence on methylation chemistry.
Radeke
H S
HS
Eugene F Merkert Chemistry Center, Boston College, Chestnut Hill, MA 02467-3860, USA.
Digits
C A
CA
Casaubon
R L
RL
Snapper
M L
ML
D000818:Animals; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D002417:Cattle; D002846:Chromatography, Affinity; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006056:Golgi Apparatus / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D008716:Methionine Adenosyltransferase / Q000378:metabolism; D008745:Methylation; D008780:Methyltransferases / Q000037:antagonists & inhibitors / Q000187:drug effects*; D010902:Pituitary Gland / Q000166:cytology / Q000201:enzymology* / Q000378:metabolism; D011809:Quinones / Q000494:pharmacology*; D012435:S-Adenosylhomocysteine / Q000378:metabolism
D004791:Enzyme Inhibitors; D011809:Quinones; C067346:illimaquinone; D012435:S-Adenosylhomocysteine; D008780:Methyltransferases; D002394:Catechol O-Methyltransferase; D008716:Methionine Adenosyltransferase